REG - Abbott Laboratories - Abbott Laboratories Files Rule 425 Document <Origin Href="QuoteRef">ABT.N</Origin>
RNS Number : 1132NAbbott Laboratories20 October 2016Notification to RNS
Company: Abbott Laboratories
TIDM: ABT
Headline: Abbott Laboratories Files Rule 425 Document
Abbott Laboratories (the "Company")
19 October 2016
Abbott Laboratories Files Rule 425 Document
The Company informs its shareholders that on 19 October 2016, a document was filed with the U.S. Securities and Exchange Commission ("SEC") pursuant to Rule 425 of the U.S. Securities Act of 1933, as amended ("Rule 425 Documents"). This Rule 425 Document can be found on the SEC website at http://www.sec.gov.
A copy of the Rule 425 Document has been submitted to the National Storage Mechanism on the date of this announcement and is, or will shortly be, available for inspection at http://www.morningstar.co.uk/uk/NSM.
Issued by: Abbott Laboratories
CONTACT: Financial, Scott Leinenweber, +1-224-668-0791, or Media, Scott Stoffel, +1-224-668-5201.
This information is provided by RNSThe company news service from the London Stock ExchangeENDDOCAKKDPABDDBKB
Recent news on Abbott Laboratories
See all newsABBOTT LABORATORIES INVESTIGATION REMINDER ALERT: Scott+Scott Attorneys at Law LLP Continues to Investigate Abbott Laboratories’ Directors and Officers for Breach of Fiduciary Duties – ABT
NewsNYSE ORDER IMBALANCE <Origin Href="QuoteRef">ABT.N</Origin> 66480.0 SHARES ON SELL SIDE
NewsUPDATE 1-Baby formula supplies improving, say U.S. retailers Walmart and Target
NewsNYSE ORDER IMBALANCE <Origin Href="QuoteRef">ABT.N</Origin> 63921.0 SHARES ON BUY SIDE
NewsWalmart says baby formula availability improving in its stores
News